Provided by Tiger Trade Technology Pte. Ltd.

BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS

342.07
-8.9300-2.54%
Volume:99.23K
Turnover:33.98M
Market Cap:39.00B
PE:61.20
High:343.68
Open:341.56
Low:336.95
Close:351.00
52wk High:385.22
52wk Low:253.95
Shares:114.00M
Float Shares:80.95M
Volume Ratio:4.57
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.59
EPS(LYR):2.47
ROE:14.66%
ROA:7.46%
PB:7.54
PE(LYR):138.49

Loading ...

BEIGENE Announces Grant of Share Options, Restricted Share Units, and Performance Share Units

Stock News
·
Jun 18

BeOne Revenue Expected to Grow on Strong Brukinsa Sales -- Market Talk

Dow Jones
·
Jun 18

BeOne Medicines Advances BGB-58067 With Key Drug-Interaction Study in Healthy Volunteers

TIPRANKS
·
Jun 18

BeOne Medicines (ONC) Gets a Buy from Barclays

TIPRANKS
·
Jun 15

BeOne Says Updated Results for Cancer Drug Tacabrutideg Show 'Durable' Responses

MT Newswires Live
·
Jun 12

BeOne Medicines announces presentation of Phase 3 data in CLL patients

TIPRANKS
·
Jun 11

BEIGENE Announces Grant of Restricted Share Units

Stock News
·
Jun 05

Analysts Offer Insights on Healthcare Companies: Repligen (RGEN), Vaxcyte (PCVX) and BeOne Medicines (ONC)

TIPRANKS
·
Jun 04

Barclays Sticks to Its Buy Rating for BeOne Medicines (ONC)

TIPRANKS
·
Jun 03

BeOne Medicines Solid Tumor Data Boost Confidence in Long-term Growth, RBC Says

MT Newswires Live
·
Jun 02

Analysts Conflicted on These Healthcare Names: BeOne Medicines (ONC), Moderna (MRNA) and Danaher (DHR)

TIPRANKS
·
Jun 02

TD Cowen Remains a Buy on BeOne Medicines (ONC)

TIPRANKS
·
Jun 02

Analysts Offer Insights on Healthcare Companies: Bioline RX Ltd Sponsored ADR (BLRX), BeOne Medicines (ONC) and Autonomix Medical, Inc. (AMIX)

TIPRANKS
·
Jun 02

RBC Capital Reaffirms Their Buy Rating on BeOne Medicines (ONC)

TIPRANKS
·
Jun 02

Beone Medicines : RBC Raises Target Price to $436 From $425

THOMSON REUTERS
·
Jun 02

BeOne Medicines Says Its Experimental Cancer Therapies Showed 'Promising' Results at ASCO 2026

MT Newswires Live
·
Jun 01

New Combo Trial in Esophageal Cancer: What LBL-007’s Phase 2 Update Means for ONC Investors

TIPRANKS
·
May 29

Hong Kong Stock Connect Biotech Sector Extends Over 8-Month Slump, Key ETF Hits Record Low

Deep News
·
May 28

BeOne Medicines’ combination shows improved survival in adenocarcinoma

TIPRANKS
·
May 28

Hang Seng Index Quarterly Review Boosts Industrial and Healthcare Sector Coverage; Six Stocks May Enter Southbound Trading

Stock News
·
May 25